三諾生物(300298.SZ)業績快報:2019年度淨利潤降17.82%至2.55億元
格隆匯2月14日丨三諾生物(300298.SZ)披露2019年度業績快報,實現營業總收入17.76億元,同比增長14.55%,營業利潤2.78億元,同比下降19.31%;利潤總額3.06億元,同比下降13.71%;歸屬於上市公司股東的淨利潤2.55億元,同比下降17.82%;基本每股收益0.4522元。
一方面,上年同期公司完成收購三諾健康管理有限公司64.98%股份對原持有的35.02%按公允價值重新計量,確認了股權增值部分的投資收益2314.32萬元,以及上年同期公司增資北京糖護科技有限公司導致可供出售金融資產持股比例增加重分類確認投資收益1133.53萬元;
另一方面,公司根據《企業會計準則第8號-資產減值》及相關會計政策規定,在2019年度報告中對商譽進行系統性減值測試,基於謹慎性原則,預計本期計提商譽減值損失為2500萬元至5000萬元;同時,受市場環境及國際銷售等因素影響,公司參股子公司深圳市心諾健康產業投資有限公司2019年處於經營虧損狀態,預計對投資收益的影響金額為-6000萬元至-7500萬元。
綜上影響,導致公司報告期內實現營業利潤、利潤總額和歸屬於上市公司股東的淨利潤同比下降。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.